Skip to content
Screener

Core Scientific, Inc. CORZ Financing Cash Flow

Financing Cash Flow at other companies

CleanSpark logo
CleanSparkCLSK
$496.38M-6.5%
TeraWulf logo
TeraWulfWULF
$965.47M+107,136%
Equinix, Inc. logo
Equinix, Inc.EQIX
-$355M-130%
Applied Digital logo
Applied DigitalAPLD
$3.26B+5,591%
Digital Realty logo
Digital RealtyDLR
-$176.5M-137%
Marathon Digital Holdings logo
Marathon Digital HoldingsMARA
-$7.71M-104%

Other financials

Income statement

See full
Revenue$164.2M+109%
Gross profit$70.0M+1,294%
Operating income-$78.5M-199%
Net income-$1.2B-23.3%
EPS (diluted)-$3.32-8,200%

Balance sheet

See full
Cash & equivalents$2.6B+339%
Total debt$4.4B+279%
Total equity-$2.4B-127%
Total assets$5.3B+166%

Cash flow

See full
Operating cash flow$249.9M+715%
CapEx$565.0M+366%
Free cash flow-$583.9M-569%

Valuation

See full
Market cap$7B+63.3%
Enterprise value$8.85B+81.9%
P/S15.9×+3.6×

Profitability

See full
Gross margin28.3%+23.2pp
Operating margin-128.5%-362pp
Net margin-237.6%-3.1pp
FCF margin-217.5%-446pp

Returns & leverage

See full
Return on equity148.5%
Debt / equity2.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Core Scientific, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Core Scientific, Inc.’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 7:08 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001839341-26-000014
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Taxes paid related to net share settlement of equity awards(35,310)
Principal payments on debt(8,613)
Other financing activities158(495)
Net cash provided by (used in) financing activities3,191,955(35,970)
Net increase (decrease) in cash, cash equivalents and restricted cash2,240,013(255,635)
Cash, cash equivalents and restricted cash—beginning of period311,378836,980
Cash, cash equivalents and restricted cash—end of period$2,551,391$581,345
Supplemental disclosure of other cash flow information:

Item 1. Financial Statements (Unaudited)

FAQ

What is Core Scientific, Inc.'s financing cash flow?
Core Scientific, Inc. (CORZ) reported financing cash flow of $2.22B in Q2 2026.
How has Core Scientific, Inc.'s financing cash flow changed year-over-year?
Core Scientific, Inc.'s financing cash flow increased by 7089.1% year-over-year, from -$31.77M to $2.22B.
What is the long-term trend for Core Scientific, Inc.'s financing cash flow?
Over 3 years (2022 to 2025), Core Scientific, Inc.'s financing cash flow has grown at a -40.9% compound annual growth rate (CAGR), from $306.16M to -$63.1M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Core Scientific, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude